Global Health Investment - aVenture Asset Manager Research
Location
New York City, NY, US
Founded
2012
Global Health Investment Corporation (GHIC) is an impact investment firm focused on advancing global health through strategic investments in life sciences and healthcare technology companies. GHIC typically invests across various stages, including Seed, Series A, Series B, and Series C rounds, aiming to accelerate the development and accessibility of innovative health solutions that improve public health and health equity worldwide.
Notable portfolio companies include Centivax, Cytovale, Micron Biomedical, and Vaxess Technologies. GHIC's investment philosophy centers on generating sustainable financial returns while making a significant social impact. The firm offers unique value-add services such as leveraging its extensive network in global health to provide strategic guidance and support to its portfolio companies. Key partners and decision-makers at GHIC bring a wealth of experience from leading organizations in the healthcare and investment sectors.
Global Health Investment - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
